Series:

On the Surface: A Literature Review

Review the latest dry eye literature

The Effects of Neurostimulation on Dry Eye Disease

Show Description +

In this year’s first episode of On The Surface, Laura M. Periman, MD, and Vance Thompson, MD, discuss the interconnection between migraine headaches, tear stimulation, trigeminal neuralgia, and dry eye disease (DED). Together, they contemplate the latest developments in neurostimulation and the future of DED treatments.

REFERENCES
Diel RJ, Hwang J, Kroeger ZA, Levitt RC, Sarantopoulos CD, Sered H, Felix ER, Martinez-Barrizonte J, Galor A. Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections. Br J Ophthalmol. 2019 Aug;103(8):1024-1029. doi: 10.1136/bjophthalmol-2018-312649. Epub 2018 Sep 29. PMID: 30269099; PMCID: PMC6440864.
*Oyster Point Pharma announces positive results in ONSET-2 phase 3 trial of OC-01 nasal spray for the treatment of the signs and symptoms of dry eye disease [press release]. Oyster Point Pharma. May 11, 2020. https://investors.oysterpointrx.com/news-releases/news-release-details/oyster-point-pharma-announces-positive-results-onset-2-phase-3. Accessed February 11, 2021.

Posted: 2/12/2021

Keywords:

Ocular surface

Dry Eye

Up Next

The Influence of Dry Eye Disease on Overall Quality of Life

Laura M. Periman, MD, Scott Schachter, OD


Prevalence of Dry Eye Disease in Sleep Apnea Sufferers

Cynthia Matossian, MD, Laura M. Periman, MD

The Role of Screen Time in Dry Eye Disease

Josh Johnston, OD, FAAO, Laura M. Periman, MD

The Intersection of Dry Eye and Glaucoma

Inder Paul Singh, MD, Laura M. Periman, MD

Dry Eye Considerations in the Preoperative Surgical Patient

Christopher E. Starr, MD, FACS, Laura M. Periman, MD

Low-Level Light Therapies

Laura M. Periman, MD; and Darrell E. White, MD

Pulsed Light Patterns and Meibomian Gland Dysfunction

Laura M. Periman, MD; and Darrell E. White, MD

Hyperkeratinization in Meibomian Gland Dysfunction

Laura M. Periman, MD; and John A. Hovanesian, MD, FACS

Treating Neuropathic Corneal Pain With Low-Dose Naltrexone

Laura M. Periman, MD; and Pedram Hamrah, MD

Analyzing the Causes of Neuropathic Corneal Pain

Laura M. Periman, MD; and Pedram Hamrah, MD

The Link Between Dry Eye, Migraine Headache Disorder, and Ocular Pain

Laura M. Periman, MD; and Anat Galor, MD, MSPH

New Methods for Analyzing and Treating Neuropathic Ocular Pain

Laura M. Periman, MD; and Anat Galor, MD, MSPH

The Effects of Neurostimulation on Dry Eye Disease

In this year’s first episode of On The Surface, Laura M. Periman, MD, and Vance Thompson, MD, discuss the interconnection between migraine headaches, tear stimulation, trigeminal neuralgia, and dry eye disease (DED). Together, they contemplate the latest developments in neurostimulation and the future of DED treatments.

REFERENCES
Diel RJ, Hwang J, Kroeger ZA, Levitt RC, Sarantopoulos CD, Sered H, Felix ER, Martinez-Barrizonte J, Galor A. Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections. Br J Ophthalmol. 2019 Aug;103(8):1024-1029. doi: 10.1136/bjophthalmol-2018-312649. Epub 2018 Sep 29. PMID: 30269099; PMCID: PMC6440864.
*Oyster Point Pharma announces positive results in ONSET-2 phase 3 trial of OC-01 nasal spray for the treatment of the signs and symptoms of dry eye disease [press release]. Oyster Point Pharma. May 11, 2020. https://investors.oysterpointrx.com/news-releases/news-release-details/oyster-point-pharma-announces-positive-results-onset-2-phase-3. Accessed February 11, 2021.

Posted: 2/12/2021

Keywords:

Ocular surface

Dry Eye

Please log in to leave a comment.

Playlist icon
Playlist - 8 Videos

Dry Eye Disease